ArticlePLOS digital health2025
Developing a youth-friendly internet-enabled HIV risk calculator: A collaborative approach with young key populations, living in Soweto, South Africa.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Although South Africa is the global epicenter of the HIV epidemic, the uptake of HIV testing and treatment among young people remains low. Concerns about confidentiality impede the utilization of HIV prevention services, which signals the need for discrete HIV prevention measures that leverage youth-friendly platforms. This paper describes the process of developing a youth-friendly internet-enabled HIV risk calculator in collaboration with young people, including young key populations aged between 18 and 24 years old. Using qualitative research, we conducted an exploratory study with 40 young people including young key population (lesbian, gay, bisexual, transgender (LGBT) individuals, men who have sex with men (MSM), and female sex workers). Eligible participants were young people aged between 18-24 years old and living in Soweto. Data was collected through two peer group discussions with young people aged 18-24 years, a once-off group discussion with the [Name of clinic removed for confidentiality] adolescent community advisory board members and once off face-to-face in-depth interviews with young key population groups: LGBT individuals, MSM, and female sex workers. LGBT individuals are identified as key populations because they face increased vulnerability to HIV/AIDS and other health risks due to societal stigma, discrimination, and obstacles in accessing healthcare and support services. The measures used to collect data included a socio-demographic questionnaire, a questionnaire on mobile phone usage, an HIV and STI risk assessment questionnaire, and a semi-structured interview guide. Framework analysis was used to analyse qualitative data through a qualitative data analysis software called NVivo. Descriptive statistics were summarized using SPSS for participant socio-demographics and mobile phone usage. Of the 40 enrolled participants, 58% were male, the median age was 20 (interquartile range 19-22.75), and 86% had access to the internet. Participants' recommendations were considered in developing the HIV risk calculator. They indicated a preference for an easy-to-use, interactive, real-time assessment offering discrete and private means to self-assess HIV risk. In addition to providing feedback on the language and wording of the risk assessment tool, participants recommended creating a colorful, interactive and informational app. A collaborative and user-driven process is crucial for designing and developing HIV prevention tools for targeted groups. Participants emphasized that privacy, confidentiality, and ease of use contribute to the acceptability and willingness to use internet-enabled HIV prevention methods.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.